Concise Review: Chronic Myeloid Leukemia: Stem Cell Niche and Response to Pharmacologic Treatment

Nowadays, more than 90% of patients affected by chronic myeloid leukemia (CML) survive with a good quality of life, thanks to the clinical efficacy of tyrosine kinase inhibitors (TKIs). Nevertheless, point mutations of the ABL1 pocket occurring during treatment may reduce binding of TKIs, being resp...

Descripción completa

Detalles Bibliográficos
Autores principales: Arrigoni, Elena, Del Re, Marzia, Galimberti, Sara, Restante, Giuliana, Rofi, Eleonora, Crucitta, Stefania, Baratè, Claudia, Petrini, Mario, Danesi, Romano, Di Paolo, Antonello
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2018
Materias:
Translational Research Articles and Reviews
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5827745/
https://www.ncbi.nlm.nih.gov/pubmed/29418079
http://dx.doi.org/10.1002/sctm.17-0175

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5827745/
https://www.ncbi.nlm.nih.gov/pubmed/29418079
http://dx.doi.org/10.1002/sctm.17-0175

Ejemplares similares